Congenital alterations of NEMO glutamic acid 223 result in hypohidrotic ectodermal dysplasia and immunodeficiency with normal serum IgG levels

Ann Allergy Asthma Immunol. 2011 Jul;107(1):50-6. doi: 10.1016/j.anai.2011.03.009. Epub 2011 May 4.

Abstract

Background: Hypomorphic mutations in the nuclear factor-κB (NF-κB) essential modulator (NEMO) gene result in a variable syndrome of somatic and immunologic abnormalities. Clinically relevant genotype-phenotype associations are essential to understanding this complex disease.

Objective: To study 2 unrelated boys with novel NEMO mutations altering codon 223 for similarity in phenotype in consideration of potential genotype-phenotype associations.

Methods: Clinical and laboratory features, including cell counts, immunoglobulin quantity and quality, natural killer cell cytotoxicity, and Toll-like and tumor necrosis factor receptor signaling, were evaluated. Because both mutations affected NEMO codon 223 and were novel, consideration was given to new potential genotype-phenotype associations.

Results: Both patients were diagnosed as having hypohidrotic ectodermal dysplasia and had severe or recurrent infections. One had recurrent sinopulmonary infections and the other necrotizing soft tissue methicillin-resistant Staphylococcus aureus infection and Streptococcus anginosus subdural empyema with bacteremia. NEMO gene sequence demonstrated a 3-nucleotide deletion (c.667_669delGAG) in one patient and a substitution (667G>A) in the other. These findings predict either the deletion of NEMO glutamic acid 223 or it being replaced with lysine, respectively. Both patients had normal serum IgG levels but poor specific antibodies. Natural killer cell cytotoxicity and Toll-like and tumor necrosis factor receptor signaling were also impaired. Serious bacterial infection did not occur in both patients after immunoglobulin replacement therapy.

Conclusions: Two different novel mutations affecting NEMO glutamic acid 223 resulted in clinically relevant similar phenotypes, providing further evidence to support genotype-phenotype correlations in this disease. They suggest NEMO residue 223 is required for ectodermal development and immunity and is apparently dispensable for quantitative IgG production but may be required for specific antibody production.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibody Specificity / immunology
  • Child, Preschool
  • Ectodermal Dysplasia / genetics
  • Ectodermal Dysplasia / immunology
  • Ectodermal Dysplasia 1, Anhidrotic
  • Humans
  • I-kappa B Kinase / genetics*
  • I-kappa B Kinase / immunology
  • Immunoglobulin G / blood*
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunologic Deficiency Syndromes / genetics*
  • Immunologic Deficiency Syndromes / immunology
  • Infant
  • Killer Cells, Natural / immunology
  • Male
  • Mutation
  • Receptors, Tumor Necrosis Factor / immunology
  • Signal Transduction / immunology
  • Toll-Like Receptors / immunology

Substances

  • IKBKG protein, human
  • Immunoglobulin G
  • Immunoglobulins, Intravenous
  • Receptors, Tumor Necrosis Factor
  • Toll-Like Receptors
  • I-kappa B Kinase